VOLUME 6 (2015)
Table of Contents
Editorial
|
| Growth hormone in adipose dysfunction and senescence |
|
https://doi.org/10.18632/oncotarget.3997
|
| 10667-10668 |
|
| iPSCMSCs and islet allograft tolerance |
|
https://doi.org/10.18632/oncotarget.4050
|
| 10669-10670 |
Reviews
|
| Genetic/molecular alterations of meningiomas and the signaling pathways targeted |
|
https://doi.org/10.18632/oncotarget.3870
|
| 10671-10688 |
|
| Mutations of cCbl in myeloid malignancies |
|
https://doi.org/10.18632/oncotarget.3986
|
| 10689-10696 |
|
| EMT CTCs and CSCs in tumor relapse and drugresistance |
|
https://doi.org/10.18632/oncotarget.4037
|
| 10697-10711 |
Priority Research Papers
|
| Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH3 mimetic |
|
https://doi.org/10.18632/oncotarget.3544
|
| 10712-10727 |
|
| Chemotherapy induces the cancerassociated fibroblast phenotype activating paracrine HedgehogGLI signalling in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.3828
|
| 10728-10745 |
|
| Complementary genetic screens identify the E3 ubiquitin ligase CBLC as a modifier of PARP inhibitor sensitivity |
|
https://doi.org/10.18632/oncotarget.3628
|
| 10746-10758 |
Research Papers: Pathology
|
| Dysfunctional BLK in common variable immunodeficiency perturbs Bcell proliferation and ability to elicit antigenspecific CD4+ Tcell help |
|
https://doi.org/10.18632/oncotarget.3577
|
| 10759-10771 |
|
| Experimental microembolism induces localized neuritic pathology in guinea pig cerebrum |
|
https://doi.org/10.18632/oncotarget.3599
|
| 10772-10785 |
|
| Global gene expression in pseudomyxoma peritonei with parallel development of two immortalized cell lines |
|
https://doi.org/10.18632/oncotarget.3198
|
| 10786-10800 |
Research Papers: Gerotarget (Focus on Aging)
|
| Ovariectomy shortens the life span of female mice |
|
https://doi.org/10.18632/oncotarget.2984
|
| 10801-10811 |
|
| A critical role of nicotinamide phosphoribosyltransferase in human telomerase reverse transcriptase induction by resveratrol in aortic smooth muscle cells |
|
https://doi.org/10.18632/oncotarget.3580
|
| 10812-10824 |
Research Papers
|
| A novel role for drebrin in regulating progranulin bioactivity in bladder cancer |
|
https://doi.org/10.18632/oncotarget.3424
|
| 10825-10839 |
|
| The long noncoding RNA HOTTIP enhances pancreatic cancer cell proliferation survival and migration |
|
https://doi.org/10.18632/oncotarget.3450
|
| 10840-10852 |
|
| The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrugresistance associated protein MRP2 |
|
https://doi.org/10.18632/oncotarget.3414
|
| 10853-10867 |
|
| microRNA217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer |
|
https://doi.org/10.18632/oncotarget.3451
|
| 10868-10879 |
|
| PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.3534
|
| 10880-10892 |
|
| Hypoxiainducible factor 1α HIF1α and reactive oxygen species ROS mediates radiationinduced invasiveness through the SDF1α/CXCR4 pathway in nonsmall cell lung carcinoma cells |
|
https://doi.org/10.18632/oncotarget.3535
|
| 10893-10907 |
|
| Metformin prevents aggressive ovarian cancer growth driven by highenergy diet: similarity with calorie restriction |
|
https://doi.org/10.18632/oncotarget.3434
|
| 10908-10923 |
|
| Quantitative phosphoproteome analysis of embryonic stem cell differentiation toward blood |
|
https://doi.org/10.18632/oncotarget.3454
|
| 10924-10939 |
|
| LLL12 a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy |
|
https://doi.org/10.18632/oncotarget.3458
|
| 10940-10949 |
|
| Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma |
|
https://doi.org/10.18632/oncotarget.3459
|
| 10950-10963 |
|
| miR942 promotes cancer stem celllike traits in esophageal squamous cell carcinoma through activation of Wnt/βcatenin signalling pathway |
|
https://doi.org/10.18632/oncotarget.3696
|
| 10964-10977 |
|
| Identification of new biomarkers for human papillary thyroid carcinoma employing NanoString analysis |
|
https://doi.org/10.18632/oncotarget.3452
|
| 10978-10993 |
|
| Oncogenic KRAS sensitizes premalignant but not malignant cells to Noxadependent apoptosis through the activation of the MEK/ERK pathway |
|
https://doi.org/10.18632/oncotarget.3552
|
| 10994-11008 |
|
| Leucinerich α2glycoprotein promotes TGFβ1mediated growth suppression in the Lewis lung carcinoma cell lines |
|
https://doi.org/10.18632/oncotarget.3557
|
| 11009-11022 |
|
| MicroRNA146a modulates Bcell oncogenesis by regulating Egr1 |
|
https://doi.org/10.18632/oncotarget.3433
|
| 11023-11037 |
|
| Low thyroid hormone levels improve survival in murine model for ocular melanoma |
|
https://doi.org/10.18632/oncotarget.3566
|
| 11038-11046 |
|
| Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis |
|
https://doi.org/10.18632/oncotarget.3567
|
| 11047-11060 |
|
| The panPI3K inhibitor GDC0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor |
|
https://doi.org/10.18632/oncotarget.3568
|
| 11061-11073 |
|
| Pygopus2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing Ecadherin expression |
|
https://doi.org/10.18632/oncotarget.3570
|
| 11074-11086 |
|
| Claudin4 is required for vasculogenic mimicry formation in human breast cancer cells |
|
https://doi.org/10.18632/oncotarget.3571
|
| 11087-11097 |
|
| Targeting of surface alphaenolase inhibits the invasiveness of pancreatic cancer cells |
|
https://doi.org/10.18632/oncotarget.3572
|
| 11098-11113 |
|
| RNAdependent protein kinase PKR depletes nutrients inducing phosphorylation of AMPactivated kinase in lung cancer |
|
https://doi.org/10.18632/oncotarget.3573
|
| 11114-11124 |
|
| High expression of small GTPase Rab3D promotes cancer progression and metastasis |
|
https://doi.org/10.18632/oncotarget.3575
|
| 11125-11138 |
|
| Expression of programmed cell death ligand 1 PDL1 and prevalence of tumorinfiltrating lymphocytes TILs in chordoma |
|
https://doi.org/10.18632/oncotarget.3576
|
| 11139-11149 |
|
| Combined inhibition of EGFR and cABL suppresses the growth of triplenegative breast cancer growth through inhibition of HOTAIR |
|
https://doi.org/10.18632/oncotarget.3441
|
| 11150-11161 |
|
| Synaptopodin2 induces assembly of peripheral actin bundles and immature focal adhesions to promote lamellipodia formation and prostate cancer cell migration |
|
https://doi.org/10.18632/oncotarget.3578
|
| 11162-11174 |
|
| Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive NMyc amplified human neuroblastoma cells to doxorubicin |
|
https://doi.org/10.18632/oncotarget.3579
|
| 11175-11190 |
|
| Low spinophilin expression enhances aggressive biological behavior of breast cancer |
|
https://doi.org/10.18632/oncotarget.3586
|
| 11191-11202 |
|
| Esophageal adenocarcinoma and obesity: peritumoral adipose tissue plays a role in lymph node invasion |
|
https://doi.org/10.18632/oncotarget.3587
|
| 11203-11215 |
|
| Global metabolic profile identifies choline kinase alpha as a key regulator of glutathionedependent antioxidant cell defense in ovarian carcinoma |
|
https://doi.org/10.18632/oncotarget.3589
|
| 11216-11230 |
|
| Resistin and interleukin6 exhibit raciallydisparate expression in breast cancer patients display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation |
|
https://doi.org/10.18632/oncotarget.3591
|
| 11231-11241 |
|
| New somatic mutations and WNK1B4GALNT3 gene fusion in papillary thyroid carcinoma |
|
https://doi.org/10.18632/oncotarget.3593
|
| 11242-11251 |
|
| E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells |
|
https://doi.org/10.18632/oncotarget.3594
|
| 11252-11263 |
|
| Lipin1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment |
|
https://doi.org/10.18632/oncotarget.3595
|
| 11264-11280 |
|
| FoxM1 promotes breast tumorigenesis by activating PDGFA and forming a positive feedback loop with the PDGF/AKT signaling pathway |
|
https://doi.org/10.18632/oncotarget.3596
|
| 11281-11294 |
|
| Sunitinib but not VEGF blockade inhibits cancer stem cell endothelial differentiation |
|
https://doi.org/10.18632/oncotarget.3123
|
| 11295-11309 |
|
| Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer |
|
https://doi.org/10.18632/oncotarget.3597
|
| 11310-11326 |
|
| Large oncosomes contain distinct protein cargo and represent a separate functional class of tumorderived extracellular vesicles |
|
https://doi.org/10.18632/oncotarget.3598
|
| 11327-11341 |
|
| The hypoxiarelated microRNA miR199a3p displays tumor suppressor functions in ovarian carcinoma |
|
https://doi.org/10.18632/oncotarget.3604
|
| 11342-11356 |
|
| Epidermal growth factor receptor as a novel molecular target for aggressive papillary tumors in the middle ear and temporal bone |
|
https://doi.org/10.18632/oncotarget.3605
|
| 11357-11368 |
|
| Intraperitoneal administration of tumortargeting Salmonella typhimurium A1R inhibits disseminated human ovarian cancer and extends survival in nude mice |
|
https://doi.org/10.18632/oncotarget.3607
|
| 11369-11377 |
|
| Bcell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin3 |
|
https://doi.org/10.18632/oncotarget.3409
|
| 11378-11394 |
|
| Distinct von HippelLindau gene and hypoxiaregulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism |
|
https://doi.org/10.18632/oncotarget.3456
|
| 11395-11406 |
|
| Population analysis of microsatellite genotypes reveals a signature associated with ovarian cancer |
|
https://doi.org/10.18632/oncotarget.2933
|
| 11407-11420 |
|
| Loss of tenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelialtomesenchymal transition |
|
https://doi.org/10.18632/oncotarget.3222
|
| 11421-11433 |
|
| Amphiregulin enhances alpha6beta1 integrin expression and cell motility in human chondrosarcoma cells through Ras/Raf/MEK/ERK/AP1 pathway |
|
https://doi.org/10.18632/oncotarget.3397
|
| 11434-11446 |
|
| Reduction in gap junction intercellular communication promotes glioma migration |
|
https://doi.org/10.18632/oncotarget.3407
|
| 11447-11464 |
|
| CD44 increases the efficiency of distant metastasis of breast cancer |
|
https://doi.org/10.18632/oncotarget.3410
|
| 11465-11476 |
|
| High frequency of loss of PTEN expression in human solid salivary adenoid cystic carcinoma and its implication for targeted therapy |
|
https://doi.org/10.18632/oncotarget.3411
|
| 11477-11491 |
|
| Metastasisassociated in colon cancer1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2 |
|
https://doi.org/10.18632/oncotarget.3416
|
| 11492-11506 |
|
| AMPKmediated energy homeostasis and associated metabolic effects on cancer cell response and resistance to cetuximab |
|
https://doi.org/10.18632/oncotarget.3432
|
| 11507-11518 |
|
| MTH1 expression is required for effective transformation by oncogenic HRAS |
|
https://doi.org/10.18632/oncotarget.3447
|
| 11519-11529 |
|
| Downregulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis |
|
https://doi.org/10.18632/oncotarget.3448
|
| 11530-11546 |
|
| Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5FU |
|
https://doi.org/10.18632/oncotarget.3413
|
| 11547-11560 |
|
| Inhibition of βCatenin signaling suppresses pancreatic tumor growth by disrupting nuclear βCatenin/TCF1 complex: critical role of STAT3 |
|
https://doi.org/10.18632/oncotarget.3427
|
| 11561-11574 |
|
| Autoimmune response to PARP and BRCA1/BRCA2 in cancer |
|
https://doi.org/10.18632/oncotarget.3428
|
| 11575-11584 |
|
| TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGFβ signaling |
|
https://doi.org/10.18632/oncotarget.3412
|
| 11585-11599 |
|
| Activation of AKR1C1/ERβ induces apoptosis by downregulation of cFLIP in prostate cancer cells: A prospective therapeutic opportunity |
|
https://doi.org/10.18632/oncotarget.3417
|
| 11600-11613 |
|
| FTY720 enhances TRAILmediated apoptosis by upregulating DR5 and downregulating Mcl1 in cancer cells |
|
https://doi.org/10.18632/oncotarget.3426
|
| 11614-11626 |
|
| ψBufarenogin a novel antitumor compound suppresses liver cancer growth by inhibiting receptor tyrosine kinasemediated signaling |
|
https://doi.org/10.18632/oncotarget.3435
|
| 11627-11639 |
|
| Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration |
|
https://doi.org/10.18632/oncotarget.3449
|
| 11640-11651 |
|
| LncRNAATB promotes trastuzumab resistance and invasionmetastasis cascade in breast cancer |
|
https://doi.org/10.18632/oncotarget.3457
|
| 11652-11663 |
|
| Recurrence of glioblastoma after radiochemotherapy is associated with an angiogenic switch to the CXCL12CXCR4 pathway |
|
https://doi.org/10.18632/oncotarget.3256
|
| 11664-11675 |
Clinical Research Papers
|
| MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomidechemoresistant subtype |
|
https://doi.org/10.18632/oncotarget.3258
|
| 11676-11682 |
|
| Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort |
|
https://doi.org/10.18632/oncotarget.3549
|
| 11683-11693 |
|
| High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis |
|
https://doi.org/10.18632/oncotarget.3429
|
| 11694-11703 |
|
| Tyrosineprotein phosphatase nonreceptor type 12 expression is a good prognostic factor in resectable nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.3588
|
| 11704-11713 |
|
| Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation |
|
https://doi.org/10.18632/oncotarget.3418
|
| 11714-11722 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
